GlaxoSmithKline

Still chasing biosimilars? Multinational pharmaceutical companies have begun to sell
Pharmaceutical companies Biocon Adalimumab GlaxoSmithKline AstraZeneca Novartis
05-07
Tianjing Biotech seeks to sell part of its business, and the capital frenzy of China's innovative drug industry has receded
Celestial creatures Zang Jingwu Innovative medicine Listed GlaxoSmithKline
04-25
Another batch of pharmaceutical companies withdrew! Involving a large number of traditional Chinese medicine varieties, Liuwei Dihuang Pill is listed
Pharmaceutical companies Collective procurement Tongrentang GlaxoSmithKline Ray Yoon on
04-01
The bivalent HPV vaccine staged a three-country killing, and Watson and Wantai surrounded and suppressed GSK
hpv GlaxoSmithKline Watson Wantai Cervical cancer vaccine
03-28
Pfizer's new crown drug entered China; Cinda PD-1 could not enter the United States; GSK executives left
Pfizer GlaxoSmithKline United States_Current affairs Covid Collective procurement
02-13
Beauty Watch | when the brutal acquisition can no longer be a good strategy for large groups to face the new era...
acquisition Unilever Makeup GlaxoSmithKline Shiseido Group L'Oréal China
01-30
How far are we from hpv-free vaccination?
hpv vaccine Cervical cancer vaccine Biomedical industry Finance and economic health GlaxoSmithKline
01-14
GlaxoSmithKline Single-Tablet Dual-Drug HIV Treatment Drug Doveto China's first medical insurance prescription landed
Human immunodeficiency virus Doveto GlaxoSmithKline Beijing You'an Hospital Dotiravir
01-04
In the fight against infectious diseases, GSK leads the way in protecting human health
GlaxoSmithKline contagious disease Covid vaccine Cyrus Cervical cancer
12-13